Resultados de procura - Matyàs Keltai
- Mostrando 1 - 20 Resultados de 43
- Go to Next Page
-
1
-
2
-
3
Dietary Patterns and the Risk of Acute Myocardial Infarction in 52 Countries por Romaina Iqbal, Sonia S. Anand, Stephanie Ôunpuu, Shofiqul Islam, Xiaohe Zhang, Sumathy Rangarajan, Jephat Chifamba, Ali T. Al‐Hinai, Matyàs Keltai, Salim Yusuf
Publicado 2008Artigo -
4
Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease por Sonia S. Anand, Salim Yusuf, Changchun Xie, Janice Pogue, John W. Eikelboom, Andrzej Budaj, Bruce Sussex, Lisheng Liu, Randolph Guzman, Claudio S. Cinà, Richard Crowell, Matyàs Keltai, Gilbert Gosselin
Publicado 2007Artigo -
5
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time por Ziad Hijazi, Stefan H. Hohnloser, Ulrika Andersson, John H. Alexander, Michael Hanna, Matyàs Keltai, Alexander Parkhomenko, José López‐Sendón, Renato D. Lópes, Agneta Siegbahn, Christopher B. Granger, Lars Wallentin
Publicado 2016Artigo -
6
Patterns of Long‐term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the <scp>TIMI</scp>‐38 Coronary... por Marc P. Bonaca, Sabina A. Murphy, Debra L. Miller, Jean‐Paul R. Herrman, Shmuel Gottlieb, Matyàs Keltai, Alberto Menozzi, José Carlos Nicolau, Petr Widimský, Elliott M. Antman, Stephen D. Wiviott
Publicado 2014Artigo -
7
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PL... por Pontus Andell, Stefan James, Christopher P. Cannon, Derek D. Cyr, Anders Himmelmänn, Steen Husted, Matyàs Keltai, Sasha Koul, Anwar Santoso, Philippe Gabríel Steg, Robert F. Storey, Lars Wallentin, David Erlinge
Publicado 2015Artigo -
8
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y <sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndrom... por Francesco Franchi, Stefan James, Tatevik Ghukasyan Lakic, Andrzej Budaj, Jan H. Cornel, Hugo A. Katus, Matyàs Keltai, Frederic Kontny, Basil S. Lewis, Robert F. Storey, Anders Himmelmänn, Lars Wallentin, Dominick J. Angiolillo
Publicado 2019Artigo -
9
Effects of Lipid‐Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE‐3 Trial por Gilles R. Dagenais, Hye Jung Jung, Eva Lonn, Peter Bogaty, Mahshid Dehghan, Claes Held, Álvaro Avezum, Petr Janský, Matyàs Keltai, Lawrence A. Leiter, Patricio López‐Jaramillo, William D. Toff, Jackie Bosch, Salim Yusuf
Publicado 2018Artigo -
10
Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Pr... por Philip Joseph, Eva Lonn, Jackie Bosch, Patricio López, Jun Zhu, Matyàs Keltai, Anthony Dans, Christopher M. Reid, Kamlesh Khunti, William D. Toff, Leopoldo Soares Piegas, Jae‐Hyung Kim, Balakumar Swaminathan, Michael Böhm, Salim Yusuf
Publicado 2017Artigo -
11
Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose por Gilles R. Dagenais, Hertzel C. Gerstein, R Holman, Andrzej Budaj, A Escalante, Thomas Hedner, Matyàs Keltai, Eva Lonn, Samy I. McFarlane, M. McQueen, Koon Teo, Patrick Sheridan, Jackie Bosch, Janice Pogue, Salim Yusuf
Publicado 2008Artigo -
12
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function por Stefan James, Andrzej Budaj, Philip E. Aylward, Kristen Buck, Christopher P. Cannon, Jan H. Cornel, Robert A. Harrington, Jay Horrow, Hugo Katus, Matyàs Keltai, Basil S. Lewis, Keyur Parikh, Robert F. Storey, Karolina Szummer, Daniel Wojdyla, Lars Wallentin
Publicado 2010Artigo -
13
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack por Stefan James, Robert F. Storey, Nardev S. Khurmi, Steen Husted, Matyàs Keltai, Kenneth W. Mahaffey, Juan Maya, João Morais, Renato D. Lópes, José Carlos Nicolau, Prem Pais, Dimitar Raev, José López‐Sendón, Susanna R. Stevens, Richard C. Becker
Publicado 2012Artigo -
14
Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic... por B. Daan Westenbrink, Marco Alings, Christopher B. Granger, John H. Alexander, Renato D. Lópes, Elaine M. Hylek, Laine Thomas, Daniel Wojdyla, Michael Hanna, Matyàs Keltai, Philippe Gabríel Steg, Raffaele De Caterina, Lars Wallentin, Wiek H. van Gilst
Publicado 2016Artigo -
15
Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial por Justin A. Ezekowitz, Basil S. Lewis, Renato D. Lópes, Daniel Wojdyla, John J.V. McMurray, Michael Hanna, Dan Atar, M. Cecilia Bahit, Matyàs Keltai, José López‐Sendón, Prem Pais, Witold Rużyłło, Lars Wallentin, Christopher B. Granger, John H. Alexander
Publicado 2015Artigo -
16
Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation por Greg Flaker, Renato D. Lópes, Elaine M. Hylek, Daniel Wojdyla, Laine Thomas, Sana M. Al‐Khatib, Renee M. Sullivan, Stefan H. Hohnloser, David García, Michael Hanna, John Amerena, Veli-Pekka Harjola, Paul Dorian, Álvaro Avezum, Matyàs Keltai, Lars Wallentin, Christopher B. Granger
Publicado 2014Artigo -
17
The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia por Louise Bordeleau, Natalia Yakubovich, Gilles R. Dagenais, Julio Rosenstock, Jeffrey L. Probstfield, Pan Chang Yu, Lars Rydén, Valdis Pīrāgs, Giatgen A. Spinas, Kåre I. Birkeland, Robert E. Ratner, José Antônio Marin‐Neto, Matyàs Keltai, Matthew C. Riddle, Jackie Bosch, Salim Yusuf, Hertzel C. Gerstein
Publicado 2014Artigo -
18
Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy por Pedro Sílvio Farsky, Jennifer A. White, Hussein R. Al‐Khalidi, Carla A. Sueta, Jean L. Rouleau, Julio A. Panza, Eric J. Velazquez, Christopher M. O’Connor, Rafał Dąbrowski, Ljubomir T. Djokovic, Mark H. Drazner, Haissam Haddad, Imtiaz S. Ali, Matyàs Keltai, Ajay Naik, George Sopko, Krzysztof S. Gołba, Bert Andersson, Peter E. Carson, Tomasz Kukulski
Publicado 2021Artigo -
19
Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction por David Wood, John A. Cairns, Jia Wang, Roxana Mehran, Robert F. Storey, Helen Nguyen, Brandi Meeks, Vijay Kunadian, Jean‐François Tanguay, Hahn-Ho Kim, Asim N. Cheema, Payam Dehghani, Madhu K. Natarajan, Sanjit S. Jolly, John Amerena, Matyàs Keltai, Stefan James, Ota Hlinomaz, Kari Niemelä, Khalid F. AlHabib, Basil S. Lewis, Michel Nguyen, Jaydeep Sarma, Vladimír Džavík, Anthony Della Siega, Shamir R. Mehta
Publicado 2019Artigo -
20
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity por Harmony R. Reynolds, Leslee J. Shaw, James K. Min, Courtney Page, Daniel S. Berman, Bernard Chaitman, Michael H. Picard, Raymond Y. Kwong, Sean M. O’Brien, Zhen Huang, Daniel B. Mark, Ranjit Kumar Nath, Sudhanshu Kumar Dwivedi, Paola Smanio, Peter H. Stone, Claes Held, Matyàs Keltai, Sripal Bangalore, Jonathan Newman, John A. Spertus, Gregg W. Stone, David J. Maron, Judith S. Hochman
Publicado 2021Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Cardiology
Myocardial infarction
Atrial fibrillation
Confidence interval
Engineering
Mechanical engineering
Randomized controlled trial
Stroke (engine)
Warfarin
Hazard ratio
Rivaroxaban
Intensive care medicine
Coronary artery disease
Disease
Aspirin
Acute coronary syndrome
Alternative medicine
Blood pressure
Clopidogrel
Pathology
Placebo
Kidney disease
Apixaban
Diabetes mellitus
Endocrinology
Surgery
Ticagrelor
Clinical endpoint